IBO — Universal Ibogaine Cashflow Statement
0.000.00%
Last trade - 00:00- CA$3.09m
- CA$5.39m
- CA$1.03m
- 11
- 46
- 27
- 18
Annual cashflow statement for Universal Ibogaine, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -10.5 | -2.39 |
| Depreciation | ||
| Non-Cash Items | 6.4 | 0.5 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.508 | 0.497 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -4.33 | -1.1 |
| Capital Expenditures | -0.096 | -0.36 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -1.99 | — |
| Acquisition of Business | ||
| Sale of Business | ||
| Sale of Fixed Assets | ||
| Cash from Investing Activities | -2.09 | -0.36 |
| Financing Cash Flow Items | 5.71 | 0.806 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 7.01 | 1.04 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.584 | -0.413 |